Código QR (código de barras bidimensional)

Relapsed and refractory classical Hodgkin lymphoma: could virotherapy help solve the equation?

Classical Hodgkin lymphoma is a neoplastic hematological disease. Standard first-line therapy, including chemotherapy and radiotherapy, is curative in >85% of early-stage patients, with a 5-year survival rate of >95%. However, approximately 15% of patients have hard-to-treat lymphoma with poor outco...

Fuld beskrivelse

Na minha lista:
Principais autores: Selma Addou, Clémentine Sarkozy, Julien Lazarovici, Stéphane Champiat, Aspasia Stamatoullas, Fabrice Jardin, Vincent Ribrag, Aurélien Marabelle, Jean-Marie Michot
Format: Artigo
Sprog:Inglês
Udgivet: Taylor & Francis Group 2021-10-01
Serier:Human Vaccines & Immunotherapeutics
Fag:
hodgkin lymphoma
virotherapy
oncolytic viruses
epstein-barr virus
Online adgang:http://dx.doi.org/10.1080/21645515.2021.1924521
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker